دورية أكاديمية

Pain-relievers prescription after bone metastasis detection in breast cancer patients: A Brazilian reference cancer hospital experience.

التفاصيل البيبلوغرافية
العنوان: Pain-relievers prescription after bone metastasis detection in breast cancer patients: A Brazilian reference cancer hospital experience.
المؤلفون: Silva TB; Medicina Nuclear, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil., Cardoso MAS; Medicina Nuclear, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil., Ramim JE; Medicina Nuclear, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil.; Programa de Epidemiologia Clínica, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil., Bergmann A; Programa de Epidemiologia Clínica, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil., Pujatti PB; Medicina Nuclear, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brasil.
المصدر: The breast journal [Breast J] 2020 Sep; Vol. 26 (9), pp. 1874-1875. Date of Electronic Publication: 2020 Feb 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 9505539 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4741 (Electronic) Linking ISSN: 1075122X NLM ISO Abbreviation: Breast J Subsets: MEDLINE
أسماء مطبوعة: Publication: 2022- : [Hoboken, New Jersey] : [London] : Hindawi Wiley ;
Original Publication: Cambridge, MA : Blackwell Science, c1995-
مواضيع طبية MeSH: Bone Neoplasms*/drug therapy , Breast Neoplasms*/drug therapy, Brazil ; Cancer Care Facilities ; Female ; Humans ; Pain ; Prescriptions
References: Parkes A, Warneke CL, Clifton K, et al. Prognostic factors in patients with metastatic breast cancer with bone-only metastases. Oncologist. 2018;23(11):1282-1288.
Niikura N, Hashimoto J, Kazama T, et al. Diagnostic performance of 18F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis. Breast Cancer. 2016;23(4):662-667.
Baba K, Kaida H, Hattori C, et al. Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases. Hell J Nucl Med. 2018;21(1):15-23.
Pires AO, Borges US, Lopes-Costa PV, Gebrim LH, da Silva BB. Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging. Eur J Obstet Gynecol Reprod Biol. 2014;180:138-141.
Zacho HD, Manresa JAB, Aleksyniene R, et al. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT. EJNMMI Res. 2017;7(1):1-7.
World Health Organization, ed. Cancer Pain Relief. Geneva: Albany, NY: World Health Organization; WHO Publications Center USA; 1986.
Suvannasankha A, Chirgwin JM. Role of bone-anabolic agents in the treatment of breast cancer bone metastases. Breast Cancer Res. 2014;16:1-9.
van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9.
تواريخ الأحداث: Date Created: 20200220 Date Completed: 20210617 Latest Revision: 20210617
رمز التحديث: 20231215
DOI: 10.1111/tbj.13782
PMID: 32072710
قاعدة البيانات: MEDLINE
الوصف
تدمد:1524-4741
DOI:10.1111/tbj.13782